$EXAM gaps +18% on FDA orphan-drug designation.
Float of just 4.2M, prior-day volume 3× the 30-day average — the catalyst-meets-low-float setup we've been writing about for fourteen years.
By Chad, Editor-in-Chief · 2 hours ago · 4 min read
Penny stocks are the part of the market where ordinary investors can occasionally find dramatic upside — and where most retail traders lose money. The same low-priced, low-float dynamics that make a stock double in a morning also make it gap down 40% on a single dilution headline.
That's the dynamic we've been writing about every week since 2011. Free, real-time email and SMS alerts on penny stocks, small caps, and day-trading setups, sent to 25,000+ traders before the market opens. No paid tier. The list is the product.
This morning's alert — $EXAM — is a clean example of the format: a 4.2M float, a real catalyst (FDA orphan-drug designation), pre-market volume already 3× the 30-day average. Subscribers got the alert at 9:31 AM ET, two hours before the move extended to +24%. Read our full penny stocks guide →